Cargando…
Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies
Increased mammographic density (MD) has been shown beyond doubt to be a marker for increased breast cancer risk, though the underpinning pathobiology is yet to be fully elucidated. Estrogenic activity exerts a strong influence over MD, which consequently has been observed to change predictably in re...
Autores principales: | Shawky, Michael S., Martin, Hilary, Hugo, Honor J., Lloyd, Thomas, Britt, Kara L., Redfern, Andrew, Thompson, Erik W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354931/ https://www.ncbi.nlm.nih.gov/pubmed/27894075 http://dx.doi.org/10.18632/oncotarget.13484 |
Ejemplares similares
-
RASSF1A Suppression as a Potential Regulator of Mechano-Pathobiology Associated with Mammographic Density in BRCA Mutation Carriers
por: Reye, Gina, et al.
Publicado: (2021) -
High mammographic density in women is associated with protumor inflammation
por: Huo, Cecilia W., et al.
Publicado: (2018) -
Mechanical Pressure Driving Proteoglycan Expression in Mammographic Density: a Self-perpetuating Cycle?
por: Reye, Gina, et al.
Publicado: (2021) -
Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer
por: Eriksson, Louise, et al.
Publicado: (2019) -
Mammographic density. Measurement of mammographic density
por: Yaffe, Martin J
Publicado: (2008)